Article Case studies Inside IR at Novo Nordisk: The Ozempic and Wegovy maker propping up the Danish economy Jan 16, 2024By Garnet Roach
Article Careers Executive orders and a career-high share price: ‘End of an era’ as AIXTRON head of IR moves to Gerresheimer after 17 years Jan 03, 2024By Garnet Roach
Article Small cap Opinion: What a non-executive director wants from IR Sep 09, 2022By Rosalind Kainyah
Article Sell side Research teaser: Sell-side notes and questions top factors in assessing earnings call success Mar 29, 2022By Garnet Roach
